Diagnos Laboratorium Utama Tbk. vs Cipta Perdana Lancar Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while Cipta Perdana Lancar Tbk. trades at Rp103 (market cap 290.76B, 2.8M 24h volume). The key difference: Diagnos Laboratorium Utama Tbk. and Cipta Perdana Lancar Tbk. are close in size by market cap, and Cipta Perdana Lancar Tbk. is more actively traded (2.8M versus 963.6K). Which is the better fit depends on your goals.
| DGNS | PART | |
|---|---|---|
Market Cap | 310.75B | 290.76B |
Volume | 963.6K | 2.8M |
Lot | 9.64K | 28K |
Turnover | 217.67M | 285.74M |
Average Price | 225.89 | 102.06 |
Value | 217.67M | 285.74M |
Indicative Equilibrium Price | 226 | 102 |
Indicative Equilibrium Volume | 1K | 3 |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT. Cipta Perdana Lancar Tbk (the Company) was established based on Notarial Deed No. 02 of Lutfi Burhan, S.H., dated June 5, 2009, Notary in Jakarta. The Company started its commercial operations in June 2009.
Read more on PART →